Podcasts about colorado anschutz medical campus

What is the single most important thing to recognize when communicating with families about vaccines? Author Sean T. O'Leary, MD, MPH, of the University of Colorado Anschutz Medical Campus and Children's Hospital Colorado joins JAMA Senior Editor Anne Cappola, MD, ScM, to discuss evidence-based approaches for discussions with parents about vaccines. Related Content: Strategies for Communicating With Parents About Vaccines

The first-ever clinical trial of ketogenic therapy for pediatric bipolar disorder is now enrolling.In March, we announced two new initiatives funded by the Baszucki Group aiming to explore ketogenic metabolic therapy in pediatric bipolar patients.The first major initiative—now actively enrolling participants—is a multi-site clinical trial conducted by four institutions within the Baszucki Group-funded Child and Adolescent Bipolar Network (CABIN): the UCLA Semel Institute, University of Cincinnati College of Medicine, University of Pittsburgh Medical Center, and University of Colorado Anschutz Medical Campus.In this video, Dr. David Miklowitz, a renowned expert in adolescent bipolar disorder and the study's lead investigator, joins Dr. Bret Scher to discuss the new trial.As a Professor of Psychiatry at the UCLA Semel Institute and Senior Clinical Research Fellow at Oxford University, Dr. Miklowitz brings decades of insight to the discussion. Together, they explore the design and objectives of this groundbreaking study and share how families in Los Angeles, Cincinnati, Denver, and Pittsburgh can take part in this important research effort aimed at transforming outcomes for young people living with bipolar disorder.In this interview you'll learn:✅ The challenges of diagnosing bipolar disorder in kids and teens✅ How family involvement impacts long-term outcomes✅ Why standard treatment approaches may not always work for adolescents✅ The potential benefits of ketogenic therapy as an adjunctive treatmentFor those interested in enrolling in the study, visit the link below to learn more about the study, the participant criteria, and how to enroll!https://clinicaltrials.gov/study/NCT06920940?term=miklowitz&rank=1Expert Featured:Dr. David Miklowitzhttps://www.uclahealth.org/providers/david-miklowitzResources Mentioned:Living Well with Bipolar Disorder by Dr. David MiklowitzCMEs Mentioned:Managing Major Mental Illness with Dietary Change: The New Science of Hopehttps://www.mycme.com/courses/managing-major-mental-illness-with-dietary-change-9616Brain Energy: The Metabolic Theory of Mental Illnesshttps://www.mycme.com/courses/brain-energy-the-metabolic-theory-of-mental-illness-9615Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

En los últimos años hemos escuchado o leído en diferentes fuentes de información sobre la alimentación intuitiva y para muchos, este tipo de alimentación construye una relación saludable con la comida. ¿En qué consiste este tipo de alimentación y cómo pueden aplicarse en pediatría o en la consulta diaria? Y un punto importante, ¿qué estrategias pueden utilizarse para fomentar una relación saludable con la comida en niños y adolescentes, especialmente en un entorno que promueve dietas y restricciones? Nuestra invitada para contestar estas y muchas preguntas más, es la Dra. Roberta Gómez Díaz Barreiro. La Dra. Roberta Gómez Díaz Barreiro realizó su residencia en Pediatría en el Instituto Nacional de Pediatría, Ciudad de México. Cuenta con un Postdoctorate Research Fellowship – Investigación Postdoctoral de la Universidad de Colorado Anschutz Medical Campus. Además, cursó una maestría Internacional de Obesidad Infantil en la Escuela Clínica y de Ciencias de la Salud en España. Actualmente trabaja como pediatra en la Ciudad de México, y es parte del Grupo Médico Pediátrico en el Hospital ABC y Hospital Ángeles. Instagram: @dra.robertagdbpediatra  Fuentes de información: Healthychildren.org Myplate.gov ¿Tienes algún comentario sobre este episodio o sugerencias de temas para un futuro podcast? Escríbenos a pediatrasenlinea@childrenscolorado.org.

In this episode of MedCast, Dr. Steven Rockower welcomes special guest Dr. Jennifer Christie. Dr. Christie is currently Division Director of Gastroenterology and Hepatology at the University of Colorado Anschutz Medical Campus. She is also the past President of the American Society for Gastrointestinal Endoscopy (ASGE). Dr. Christie talks about the Colorectal Cancer Screening Project that MedChi is championing in Maryland with ASGE, the importance of routine screenings, and more.

Guest: Cristin Welle, PhD To address the concerning effects of demyelinating events in patients with multiple sclerosis (MS), a recent study explored whether neuromodulation could support myelin repair and restoration of function. Learn more as Dr. Cristin Welle explains how vagus nerve stimulation has the potential to play a role in remyelination. Dr. Cristin Welle is a Professor of Neurosurgery and Physiology at the University of Colorado Anschutz Medical Campus, and she spoke about this topic at the ACTRIMS Forum 2025.

William Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Wendy Tzou, MD, FHRS, University of Colorado Anschutz Medical Campus, and Arif Elvan, MD, PhD, Klinikum Braunschweig, to discuss a partial delineation of targets for ablation of ventricular tachycardia (VT) during a stable rhythm is likely responsible for a suboptimal success rate. The abnormal low-voltage near-field functional components may be hidden within the high-amplitude far-field signal. https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.jacep.2024.04.023 Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic   Contributor Disclosure(s): A.  Elvan: Honoraria/Speaking/Consulting: Abbott Medical  W. Tzou: Honoraria/Speaking/Consulting/Teaching: Medtronic, Biotronik, Mediasphere Medical, Biosense Webster, Inc., American Heart Association, Abbott, Boston Scientific, Membership on Advisory Committees: Medtronic, Inc., Biosense Webster, Inc., Kardium, BioTelemetry, Inc., Research: Abbott Medical This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365 https://www.heartrhythm365.org/URL/TheLeadEpisode92

  It can be difficult to manage the different aspects of our lives. In this episode, we cover how to recognize and prevent burnout, how to implement personal care, and more.       Read the text version       Contact the Agent Survival Guide Podcast! Email us ASGPodcast@Ritterim.com or call 1-717-562-7211 and leave a voicemail.     Resources:   Get Focused with These Apps: https://lnk.to/asga76   Lessons Learned in 2024: https://lnk.to/asg637   Setting SMART Goals in 2025: https://lnk.to/asgf20250103   Tech Takeaways for Forward-Thinking Insurance: https://ritterim.com/blog/tech-takeaways-for-forward-thinking-insurance-agents/   Why Gen Z is a Good Fit for Selling Insurance: https://lnk.to/asg640     References:   Tartakovsky, Margarita. “7 Reasons You Might Resist Rest and How to Get Mental Rest.” Psych Central, Psych Central, 12 Jan. 2023, https://psychcentral.com/blog/how-to-really-rest.   “America's Alarming (Lack of) Work-Life Balance.” ELVTR, ELVTR, 14 Oct. 2024, https://elvtr.com/blog/americas-alarming-lack-of-work-life-balance.   Nastasi, Jessica A., et al. “Breaks and productivity: An exploratory analysis.” Journal of Applied Behavior Analysis, vol. 56, no. 3, 11 May 2023, pp. 539–548, https://onlinelibrary.wiley.com/doi/10.1002/jaba.995?utm_campaign=WRH_6_5_23.   Godreau, Jeanette. “Embrace These 7 Types of Rest.” Mindful Health Solutions, 12 June 2023, https://mindfulhealthsolutions.com/embrace-these-7-types-of-rest/.   “Hello Sunshine.” CU Anschutz Newsroom, University of Colorado Anschutz Medical Campus, 30 May 2024, https://news.cuanschutz.edu/health-and-wellness/hello-sunshine.   “Stay Focused, Be Present.” Forest, https://www.forestapp.cc/. Accessed 9 Jan. 2025.   Raeburn, Alicia. “The Productivity Hack That Actually Works [2024].” Asana, Asana, 14 Oct. 2024, https://asana.com/resources/pomodoro-technique.   “Why Our Attention Spans Are Shrinking, with Gloria Mark, Phd.” American Psychological Association, American Psychological Association, https://www.apa.org/news/podcasts/speaking-of-psychology/attention-spans. Accessed 9 Jan. 2025.      Follow Us on Social!  Ritter on Facebook, https://www.facebook.com/RitterIM Instagram, https://www.instagram.com/ritter.insurance.marketing/ LinkedIn, https://www.linkedin.com/company/ritter-insurance-marketing TikTok, https://www.tiktok.com/@ritterim X (fka) Twitter, https://twitter.com/RitterIM and Youtube, https://www.youtube.com/user/RitterInsurance      Sarah on LinkedIn, https://www.linkedin.com/in/sjrueppel/ Instagram, https://www.instagram.com/thesarahjrueppel/ and Threads, https://www.threads.net/@thesarahjrueppel    Tina on LinkedIn, https://www.linkedin.com/in/tina-lamoreux-6384b7199/     Not affiliated with or endorsed by Medicare or any government agency. 

In today's episode, we had the pleasure of speaking with Alec Watson, MD, a thoracic oncology fellow in the School of Medicine in the Division of Medical Oncology at the University of Colorado Anschutz Medical Campus in Aurora. In our exclusive interview, Dr Watson discussed the rationale for and key findings from a retrospective analysis examining the ways that oncogene overlap could identify clinically relevant thresholds for MET, KRAS, and HER2 gene copy number gain in non–small cell lung cancer; next steps for this research; and the future implications of these findings.

LET'S TALK ABOUT TRAUMATIC BRAIN INJURY FOR A MINUTE Because I've got Javan Bair from the Marcus Brain Health Institute on today at 2pm. The Marcus Institute for Brain Health (MIBH) at the University of Colorado Anschutz Medical Campus is a clinical care and research institute for traumatic brain injury (TBI) and psychological health (PH) conditions such as post-traumatic stress (PTS). Our mission is to deliver in-depth, interdisciplinary precision medicine to Active Service Members, Veterans, and First Responders with ongoing symptoms following a mild to moderate TBI. Lots of veterans struggle with the symptoms of long ago TBI and there is help available. Find out more by clicking here.

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/political-science

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/sports

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/american-studies

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/public-policy

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/education

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/politics-and-polemics

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/law

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices

Football is the national game in the United States – and many families and friends bond over their love of the sport. While few people play professional football, many participate in tackle football as children and adolescents. In the last decades, more attention has been paid to the dangers of playing tackle football, including traumatic brain injury and the degenerative brain disease, CTE (chronic traumatic encephalopathy). As more former players donated their brains, the rate of CTE surprised even those already concerned with traumatic brain injury. If the risks are so great, why do more than two million American children under the age of 18 continue to play tackle football? Is it the opportunity to contribute to a team? Overcome adversity? Test personal limits? In Tackle Football and Traumatic Brain Injuries: Law, Ethics, and Public Health (Johns Hopkins UP, 2024), Dr. Daniel S. Goldberg asks readers to think about American tackle football as an industry – like the American tobacco industry – that sells a product that is dangerous to those who use it. Despite the clearly documented costs to society and individuals who play, the tackle football industry has successfully manufactured doubt about the health hazards. Goldstein argues that a basic familiarity with the history of regulated industries and their intersection with public health is needed both to understand the contemporary debates and to move forward with fair and equitable policy solutions. If the risks to people who play were better known to the public, the profitability and perhaps even the viability of American football would be at risk. Goldberg draws on public health ethics, public health law, and the histories of occupational and public health to assess the limits of parental choice to expose their children to risks of injury. Goldberg recommends using public health laws to counter the manufacture of doubt – offering specific policy proposals to address the population health and ethical problems presented by tackle football. Daniel S. Goldstein, JD, PhD is an associate professor at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus. He is the director of Education at the Center for Bioethics and Humanities and director of the Public Health Ethics and Law Program. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/book-of-the-day

Listeners, please welcome Courtney Manthey to the show ...as a guest! In this episode, Courtney takes a break from running the HBA social media accounts and being on the elected student committee to talk about her research regarding Polycystic Ovarian Syndrome. Also, the human biology word of the day is: hirsutism. Find the publication discussed in today's episode via this citation: Manthey, C., Cepon-Robins, T., & Warrener, A. (2024). Hyperandrogenism associated with polycystic ovary syndrome may have a protective effect against fracture risk in female athletes: A pilot study. American journal of human biology : the official journal of the Human Biology Council, 36(8), e24070. https://doi.org/10.1002/ajhb.24070 ------------------------------------------------------------ Courtney Manthey is a PhD student at the University of Montana, where she studies ancient DNA under the guidance of Dr. Meradeth Snow. She is also a Research Affiliate at the University of Colorado Colorado Springs, a Research Collaborator on the Rural Embodiment and Community Health (REACH) project, and Project Manager for the NSF-funded project, “The Effects of Shared Markers of Identity on Inflammation and Stress,” among other initiatives. Courtney's research interests include reproductive health, maternal-fetal evolutionary genetics, energetics, and women's diseases. She is the Principal Investigator for the "PCOS in the Pacific" project, which examines the prevalence of polycystic ovary syndrome across the Pacific region through ancient DNA and disease prevalence studies, as well as the "PCOS Patient, Partner, Parent Stigma" project. Additionally, Courtney serves on the research and patient advisory boards of the National Polycystic Ovary Syndrome Association and the PCOS Multidisciplinary Clinic at the University of Colorado Anschutz Medical Campus. She is also a Patient Family Partner at the Preeclampsia Foundation and a Junior Service Fellow at the Human Biology Association. In her free time, Courtney is a childbirth doula, specializing in supporting adolescent mothers through the birthing process. ------------------------------------------------------------ Courtney Manthey, Special Guest, Website: www.HolyLaetoli.com/ E-mail: cpierce4@uccs.edu Chris Lynn, HBA Public Relations Committee Chair Website: cdlynn.people.ua.edu/, E-mail: cdlynn at ua.edu, Cara Ocobock, Website: sites.nd.edu/cara-ocobock/, Email:cocobock@nd.edu Facebook: www.facebook.com/groups/humanbiologyassociation Website: humbio.org/, Instagram: humbioassoc

In this special Complex Care Journal Club podcast episode, co-hosts Drs. Kilby Mann and Kristie Malik interview presenters of posters and oral abstracts relevant to the care of children with medical complexity at the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) 78th Annual Meeting in Quebec City, Canada that took place October 23rd-26th 2024. Speakers describe the implications of their study findings, messages for patients and families, and priority areas for research that they hope can be investigated further by the complex care community in the coming years. SPEAKERS Tori Bahr, MD MedPeds Complex Care Physician Section Chief of Pediatrics Gillette Children's, St. Paul, Minnesota Laura Brunton, PT, PhD Associate Professor School of Physical Therapy Western University, London, Ontario Caitlin Cassidy, MD Associate Professor Departments of Physical Medicine & Rehabilitation and Pediatrics Western University, London, Ontario Adam Rosenbloom, MD, MPH Complex Care Pediatrician Dell Children's Medical Center University of Texas at Austin, Dell Medical School Cristina Sarmiento, MD Assistant Professor Department of Physical Medicine and Rehabilitation University of Colorado Anschutz Medical Campus, Aurora, Colorado Julie Stutzbach, PT, DPT, PhD Assistant Professor School of Rehabilitative and Health Sciences Regis University, Denver, Colorado HOSTS Kristina Malik, MD Assistant Professor of Pediatrics, University of Colorado School of Medicine Medical Director, KidStreet Pediatrician, Special Care Clinic, Children's Hospital Colorado Kilby Mann, MD Assistant Professor Pediatric Rehabilitation Medicine Children's Hospital Colorado DATE Initial publication date: November 11, 2024. ARTICLES AND ADDITIONAL REFERENCES • American Academy for Cerebral Palsy and Developmental Medicine (AACPDM), https://www.aacpdm.org/ • AACPDM Complex Care Committee (https://www.aacpdm.org/about-us/committees/complex-care) • Houtrow AJ, Hurwitz MB. A dearth of disability-related competencies in Accreditation Council for Graduate Medical Education's Milestones 2.0. PM R. 2024 Aug 23. doi: 10.1002/pmrj.13257. Epub ahead of print. PMID: 39177053. • Fehlings D, Agnew B, Gimeno H, Harvey A, Himmelmann K, Lin JP, Mink JW, Monbaliu E, Rice J, Bohn E, Falck-Ytter Y. Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update. Dev Med Child Neurol. 2024 Sep;66(9):1133-1147. doi: 10.1111/dmcn.15921. Epub 2024 Apr 19. PMID: 38640091. • AACPDM Care Pathway Dystonia in Cerebral Palsy, https://www.aacpdm.org/publications/care-pathways/dystonia-in-cerebral-palsy TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/as/p9pj6g7sxn5kjmmgps5wnk4/111124_-_Complex_Care_at_the_American_Academy_for_Cerebral_Palsy_and_Developmental_Medicine_Annual_Meeting Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user.For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu CITATION Malik K, Bahr T, Brunton L, Cassidy C, Rosenbloom A, Sarmiento C, Stuzbach J, Mann K. Complex Care at the American Academy for Cerebral Palsy and Developmental Medicine Annual Meeting. 11/2024. OPENPediatrics. Online Podcast.. https://soundcloud.com/openpediatrics/complex-care-at-the-aacpdm-2024.

Check the end of any recent study, and there will be a list of study funders and disclosures about competing interests. It's important to know about potential biases in research, but this kind of transparency was not always the norm. Understanding bias in research and helping policymakers use the most reliable evidence to guide their decisions is a science in itself. Lisa Bero, a professor at the University of Colorado Anschutz Medical Campus, has been at the forefront of understanding how corporate funding biases research and how to assess what scientific evidence is reliable. She talks to host Monya Baker about her investigations into the tobacco and pharmaceutical industries, techniques industries use to shape evidence to favor their products, and the importance of independent research to inform policy.  Resources:  Read The Cigarette Papers to learn more about Lisa Bero and others' investigations of the tobacco industry.  See this analysis of industry documents about insider knowledge of health effects of PFAS and related chemicals.  Visit the Cochrane Library to find more systematic reviews of clinical research.  Learn more about Adrian Traeger's investigation of spinal cord stimulation research by reading Corporate Influences on Science and Health—the Case of Spinal Cord Stimulation. Read Lisa Bero's summary of how industry forces suppress unfavorable research.  Lisa Bero and others are developing a tool to screen for signs of fraud in clinical research. Learn more about it in The Conversation. 

Tune in to this episode of "Compliance Conversations" where we dive deep into the world of innovation and biotech with our special guest, Steve VanNurden! In this episode, CJ Wolf, MD, talks with Steve VanNurden, CEO of Fitzsimons Innovation Community and Associate Vice Chancellor of Biotechnology at the University of Colorado Anschutz Medical Campus. Listen in as they explore the unique integration of academic and entrepreneurial ecosystems, discuss the reinvention of tech transfer, and reveal the keys to building a thriving biotech community. You'll hear: The vision behind Fitzsimons Innovation Community and its role in advancing healthcare innovation. - The unique benefits of integrating academic medical centers and biotech communities. - Real-life examples of startups and research breakthroughs happening in Colorado – and why it's a powerful hub for healthcare innovation. - How the Community addresses regulatory and funding challenges to accelerate innovation. - Whether you're in healthcare, compliance, biotech, or simply passionate about innovation, this episode offers valuable insights and inspiration.

Fort Lewis College has partnered with the University of Colorado Anschutz Medical Campus to establish a new nursing training facility on its campus. U.S. Sen. John Hickenlooper toured the facility on Aug. 29, highlighting the importance of local educational opportunities in retaining healthcare professionals in rural areas. $1.3 million in federal funding will support the CU Nursing Fort Lewis College Collaborative, which aims to train students in community-based, rural, and Indigenous healthcare perspectives. By keeping nursing education local, the program seeks to address the challenges smaller communities face in recruiting healthcare workers and enhance the quality of care available in southwest Colorado. By Sadie Smith.  Watch this story at www.durangolocal.news/newsstories/senator-hickenlooper-tours-new-nursing-training-facility-at-fort-lewis-college  This story is sponsored by Tafoya Barrett & Associates and M&R Plumbing. Support the show

Digital dating apps have brought new terms to the fore, but what do they mean? Danielle Sukenik, instructor in psychiatry at the School of Medicine at the University of Colorado Anschutz Medical Campus, explores these. Danielle Sukenik is a licensed marriage and family therapist with over 12 years of clinical experience based in Denver, Colorado […]

The city of Aurora is debunking claims that an Aurora apartment building has been "taken over" by Venezuelan gangs. While the city doesn't dismiss that there is a possibility of gang activity and they're looking for a connection, the building at East Colfax Avenue and Nome Street has issues of poor living conditions dating back years. The building near the University of Colorado Anschutz Medical Campus, operated by CBZ Management, has documented issues like rodent infestations, piled up trash, missing windows, sewage backups and water leaks. It's at the point where the property management group hasn't paid their water bill. Tenants have faced issues like lack of electricity and heat, according to the city.

Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on drugs to help patients manage their pain.In this episode, a pain management specialist discusses new developments in pain treatment and why there's hope for patients with chronic pain. Rachael Rzasa Lynn Associate Professor of Anesthesiology, University of Colorado Anschutz Medical Campus speaks to Amanda Mascarelli Senior Health and Medicine Editor at The Conversation in the US about emerging chronic pain treatments.This episode was written and produced by Katie Flood with assistance from Mend Mariwany. Eloise Stevens does our sound design, and our theme music is by Neeta Sarl. Gemma Ware is the executive editor. Full credits available here. Subscribe to a free daily newsletter from The Conversation. To support what we do, please consider donating to The Conversation.Further reading:Chronic pain can be objectively measured using brain signals – new researchUnderstanding that chronic back pain originates from within the brain could lead to quicker recovery, a new study findsHow cannabis and psilocybin might help some of the 50 million Americans who are experiencing chronic pain Hosted on Acast. See acast.com/privacy for more information.

In this episode of The Future Conceived, Dr. Victor A. Ruthig, University of Colorado Anschutz Medical Campus, sits down with Rhasaan Bovell, a third-year PhD candidate conducting cheetah research at Cornell University and the Smithsonian National Zoo & Conservation Biology Institute. Listen in as Rhasaan updates us on advances in cheetah conservation since our last podcast on the topic in 2022. Rhasaan also talks about his scientific journey and shares advice to young blossoming scientists.

At the 2024 European Hematology Association (EHA) Congress, CancerNetwork® spoke with a variety of experts in the hematologic oncology space about optimizing outcomes across different patient populations and subgroups based on updated research they presented at the meeting.  Manali Kamdar, MD, an associate professor of medicine-hematology and clinical director of Lymphoma Services at the University of Colorado Anschutz Medical Campus, in Colorado, spoke about data from the phase 1 TRANSCEND NHL 001 trial (NCT02631044) supporting the use of lisocabtagene maraleucel (liso-cel; Breyanzi) in earlier lines of therapy for patients with relapsed/refractory mantle cell lymphoma (MCL).1  Specifically, Kamdar highlighted how research should continue to focus on the potential utility of liso-cel in MCL subgroups such as those with TP53 mutations or blastoid morphology. Additionally, she stated that liso-cel may need to be further tested in earlier lines of therapy for patients with diffuse large B-cell lymphoma, including those with double-hit lymphoma. Michael R. Grunwald, MD, chief of the Leukemia Division and director of the Transplantation and Cellular Therapy Program at Atrium Health's Levine Cancer Institute, in North Carolina, discussed findings from the Prospective Observational Study of Patients With Polycythemia Vera (PV) in US Clinical Practices Trial (REVEAL) exploring risk factors for disease progression in patients with polycythemia vera (PV).2 According to Grunwald, a history of thromboembolic events, elevated white blood cell counts, and higher variant allele frequencies may contribute to a patient's likelihood of experiencing progression to myelofibrosis or acute myeloid leukemia (AML). Additionally, he highlighted ongoing research into the potential molecular factors that may prognosticate disease transformation in PV among a small cohort of patients enrolled on the REVEAL trial.3 Harry P. Erba, MD, PhD, a professor of medicine in the Division of Hematologic Malignancies and Cellular Therapy and the director of the Leukemia Program and Phase I Development in Hematologic Malignancies at Duke Cancer Institute, in North Carolina, discussed the clinical implications of data from the phase 3 QuANTUM-First study (NCT02668653).4  Specifically, findings demonstrated that continuation therapy with quizartinib (Vanflyta) elicited a more pronounced survival benefit vs placebo in patients with newly diagnosed FLT3-ITD–positive AML who did not undergo allogeneic hematopoietic stem cell transplant (allo-HSCT). However, Erba noted that survival outcomes were not significantly different in the quizartinib and placebo arms among patients who received allo-HSCT. References 1.        Palomba ML, Siddiqi T, Gordon LI, et al. Subgroup analyses in patients with R/R MCL treated with lisocabtagene maraleucel by prior lines of therapy and response to Bruton tyrosine kinase inhibitor from the TRANSCEND NHL 001 MCL cohort. Presented at the European Hematology Association (EHA) 2024 Congress; Madrid, Spain; June 13-16, 2024. P1126. 2.        Grunwald M, Zwicker J, Gerds A, et al. A real-world evaluation of risk factors for disease progression in patients with polycythemia vera (PV) enrolled in REVEAL. Presented at the 2024 European Hematology Association (EHA) Congress; June 13-16, 2024; Madrid, Spain. Abstract P1047. 3.        Crowgey E, Timmers C, Xue Z, et al. Analysis of molecular mechanisms and predictive biomarkers of disease transformation in polycythemia vera. Presented at the 2024 European Hematology Association (EHA) Congress; June 13-16, 2024; Madrid, Spain. Abstract S217. 4.        Sekeres MA, Erba H, Montesinos P, et al. QuANTUM-First: efficacy in newly diagnosed patients with FMS-like tyrosine kinase 3-internal tandem duplication–positive (FLT3-ITD+) acute myeloid leukemia (AML) who received continuation therapy. Presented at the 2024 European Hematology Association (EHA) Congress; June 13-16, 2024; Madrid, Spain. Abstract S142.

The Cochrane Eyes and Vision US Project prepares and maintains reviews across a wide range of conditions. These include neovascular age-related macular degeneration and their new review of its treatment by anti-vascular endothelial growth factor biosimilars was published in June 2024. Here's one of the authors, Sueko Ng from the Department of Ophthalmology in the University of Colorado Anschutz Medical Campus in the USA, to tell us more about the condition and this treatment.

The Cochrane Eyes and Vision US Project prepares and maintains reviews across a wide range of conditions. These include neovascular age-related macular degeneration and their new review of its treatment by anti-vascular endothelial growth factor biosimilars was published in June 2024. Here's one of the authors, Sueko Ng from the Department of Ophthalmology in the University of Colorado Anschutz Medical Campus in the USA, to tell us more about the condition and this treatment.

The Cochrane Eyes and Vision US Project prepares and maintains reviews across a wide range of conditions. These include neovascular age-related macular degeneration and their new review of its treatment by anti-vascular endothelial growth factor biosimilars was published in June 2024. Here's one of the authors, Sueko Ng from the Department of Ophthalmology in the University of Colorado Anschutz Medical Campus in the USA, to tell us more about the condition and this treatment.

In this episode of The Future Conceived, Dr. Victor A. Ruthig, University of Colorado Anschutz Medical Campus, sits down with Dr. Bruce D. Murphy, University of Montreal. Dr. Murphy is the 2023 recipient of SSR's highest honor, The Carl G. Hartman award. Listen in as Dr. Murphy discusses his research trajectory and being the 2023 Carl G. Hartman award recipient. Dr. Murphy also gives some sage wisdom about mentorship and speculates about where the field of reproductive biology is headed. Dr

Achieving Success with Olivia Atkin Episode 80 "Achieve Impact: Bridging Communities in Medicine And Media with Actor Jocko Sims and Dr. Nia Mitchell"Olivia talks personal and professional achievements with Actor Jocko Sims and Doctor Nia Mitchell. Introducing Jocko Sims, an actor and producer known for his roles in "New Amsterdam", "How to Die Alone", "The Last Ship" and "The Resident". Beyond his acting career, Jocko is deeply committed to giving back to his communities. He serves as an ambassador for Hidden Heroes, a foundation established by the Elizabeth Dole Foundation to support caregivers of wounded or ill veterans. Additionally, Jocko started the More Black Doctors initiative that supports increasing the representation of Black doctors in the healthcare system. Currently, he's working with Dr. Nia S. Mitchell from The Mile High Medical Society to raise funds for the Charles J. Blackwood Endowed Memorial Scholarship Fund, supporting black medical students at the University of Colorado. Now, let's turn our attention to Dr. Nia S. Mitchell, MD, MPH. Dr. Mitchell earned her medical degree from Washington University in St. Louis and completed her residency and research fellowship at the University of Colorado Anschutz Medical Campus. She's an associateprofessor of General Internal Medicine at Duke University, focusing her research on weight loss interventions for underserved populations. Dr. Mitchell's dedication to improving healthcare access and outcomes for marginalized communities is commendable, and her contributions to the field of medicine are invaluable.Join Olivia every Tuesday as she brings on top notch guests to talk about how they are Achieving Success! Career Development Book and More at Achieving-success.comStay Connected With Us:LinkedIn: https://www.linkedin.com/company/achieving-success-llcInstagram: @_achievingsuccessTwitter: @_achievesuccessConnect with Actor Jocko Sims and Dr. Nia Mitchell's Community Outreach Websites:More Black Doctors Website: More | More Black DoctorsCharles J. Blackwood Endowed Memorial Scholarship Fund Donation Page: Charles J. Blackwood, MD, Endowed Memorial Scholarship Fund | CU Anschutz | Giving to CUElizabeth Dole Foundation Website: The Elizabeth Dole Foundation

In this episode of the Healthy, Wealthy, and Smart Podcast, we delve into making physical therapy clinics more inclusive for everyone, including the LGBT+ community. Our guest, Dr. Michelle Stauffer, a dedicated advocate for LGBT+ healthcare and a member of the APTA PT Proud Special Interest Group, shares her insights and experiences. Dr. Stauffer discusses her journey into physical therapy, influenced by her athletic injuries and her identity as a member of the LGBT+ community. She highlights the importance of creating a safe and welcoming environment in healthcare settings, especially for those who often face discrimination and misunderstanding. We explore practical steps to assess and enhance the inclusivity of a physical therapy clinic, starting from the exterior accessibility and moving inside to the waiting areas, treatment spaces, and restrooms. Dr. Stauffer emphasizes the significance of details such as inclusive signage, diverse representation in clinic decor, and thoughtful amenities that cater to a wide range of needs. Additionally, we touch on the importance of inclusive paperwork and intake forms that respect all identities by allowing patients to specify their preferred names and pronouns. Dr. Stauffer also suggests resources for continuous learning and improvement in DEI (Diversity, Equity, and Inclusion) practices, encouraging clinic owners and therapists to seek education and adapt to better serve their communities actively. This episode is packed with actionable advice for healthcare professionals who want to foster an inclusive atmosphere in their practices and ensure that all patients feel respected, safe, and valued. Time Stamps:    00:00:02 - Introduction and Guest Introduction Host Dr. Karen Litzy introduces herself and welcomes Dr. Michelle Stauffer, discussing her background and expertise in providing care to the LGBT+ community. 00:01:15 - Dr. Stauffer's Journey to Physical Therapy Dr. Stauffer shares her personal journey of becoming a physical therapist, including her athletic background and injuries. 00:05:05 - Creating an Inclusive Clinic Discussion begins on how to assess and ensure a physical therapy clinic is inclusive, starting from the external appearance to internal operations. 00:10:03 - Accessibility and External Clinic Features Dr. Stauffer discusses the importance of accessibility and external features of a clinic that can make it more inclusive. 00:16:37 - Involving Patients in Clinic Decor Ideas on how involving patients in the clinic's decor can help in creating a more inclusive environment. 00:17:03 - Inclusive Paperwork and Forms Tips on how to make intake forms and other paperwork more inclusive, including the use of open-ended questions and preferred name sections. 00:26:05 - Inside the Clinic: Waiting Area and Treatment Rooms Suggestions for making the waiting area and treatment rooms welcoming and inclusive for all patients. 00:33:09 - Restroom and Changing Room Considerations Discussion on how to make restrooms and changing rooms accessible and comfortable for everyone, including stocking necessary supplies. 00:39:02 - Staff Training on DEI The importance of continuous staff training on Diversity, Equity, and Inclusion (DEI) and resources for learning more about DEI practices. 00:45:24 - Final Thoughts and How to Connect Dr. Stauffer shares final thoughts on making clinics inclusive and provides contact information for further resources and personal connection.   More About Dr. Michelle Stauffer:   Dr. Michelle Stauffer (she/her) is a Doctor of Physical Therapy and Board Certified Health Wellness Coach who has spent her career focusing on under-resourced communities. Dr. Stauffer received her Doctorate in Physical Therapy from the University of Colorado Anschutz Medical Campus and upon completion, she began her journey of working with the LGBTQIA+ community. Dr. Stauffer founded Coast 2 Coast Wellness in 2021 with the mission of providing an inclusive & safe atmosphere while receiving affordable & quality care.    Dr. Stauffer specializes in orthopedic and sports injuries and is a Certified Sports Medical Emergency Responder and Level 2 Trigger Point Dry Needling Certified Clinician. Dr. Stauffer is the programming chair of the PT Proud Special Interest Group of the American Physical Therapy Association (APTA); a group whose purpose is to improve healthcare access for LGBTQIA+ individuals. She also is a member of the Colorado APTA PT Diversity, Equity, and Inclusion Committee. When not working, you can find Dr. Stauffer outdoors hiking or camping with her dog, or tending to her flower and vegetable gardens in her yard.     Resources from this Episode: Dr. Stauffer's Website Dr. Stauffer Instagram Dr. Stauffer TikTok Simple Steps to Create and Inclusive Workplace    Jane Sponsorship Information: Book a one-on-one demo here Mention the code LITZY1MO for a free month     Follow Dr. Karen Litzy on Social Media: Karen's Twitter Karen's Instagram Karen's LinkedIn   Subscribe to Healthy, Wealthy & Smart: YouTube Website Apple Podcast Spotify SoundCloud Stitcher iHeart Radio

In our latest episode, Consulting Editor Dr. Kristine DeLeon-Pennell (Medical University of South Carolina) interviews fellow co-authors Dr. Charlotte Usselman (McGill University), Dr. Judy Regensteiner (University of Colorado Anschutz Medical Campus), Dr. Kerrie Moreau (University of Colorado Anschutz Medical Campus), Dr. Austin Robinson (Indiana University Bloomington), Dr. Jesse Moreira-Bouchard (Boston University), and Dr. Quin Denfeld (Oregon Health and Science University) about their recently published guidelines on the use of sex and gender in cardiovascular research. Until recently, the effects of sex and gender in cardiovascular research have been largely ignored in research design and reporting. The result is that women and gender diverse individuals have been understudied in basic and clinical research, leading to a lack of understanding of sex and gender in cardiovascular health and disease. The goal of these guidelines is to provide researchers with practical and actionable advice on best practices to include sex and gender considerations in study design, data collection, analysis, and interpretation. As Dr. Judy Regensteiner points out, “We have to make it doable. We can't just say, ‘Go do this.' We have to show people how to do it.” Ready to get started? Listen now to learn more.   Charlotte W. Usselman, Merry L. Lindsey, Austin T. Robinson, Beth A. Habecker, Chloe E. Taylor, W. David Merryman, Derek Kimmerly, Jeffrey R. Bender, Judith G. Regensteiner, Kerrie L. Moreau, Louise Pilote, Megan M. Wenner, Myles O'Brien, Timur O. Yarovinsky, Nina S. Stachenfeld, Nisha Charkoudian, Quin E. Denfeld, Jesse D. Moreira-Bouchard, W. Glen Pyle, and Kristine Y. DeLeon-Pennell Guidelines on the use of sex and gender in cardiovascular research Am J Physiol Heart Circ Physiol, published December 21, 2023. DOI: 10.1152/ajpheart.00535.2023

In this episode of the Healthy, Wealthy, and Smart podcast, host Dr. Jenna Kantor talks with Dr. Alyssa Arms about the pros and cons of niche podcasting. They delved into the world of niche podcasting and the ins and outs of running a successful podcast focused on dance medicine. Dr. Arms shared valuable insights on the pros and cons of niche podcasting, the challenges of time management, and the importance of staying consistent. Here are some key takeaways from our discussion: ·       Time Management: Running a niche podcast requires significant time and effort, from recording and editing episodes to promoting them on various platforms. ·       Financial Investment: Starting a niche podcast doesn't have to break the bank. Dr. Arms shared that she spent around $200-$300 on equipment and hosting services. ·       Audience Engagement: While it can be challenging to gauge audience feedback, engaging with guests and sharing valuable content can help build a loyal following. ·       Networking Opportunities: Interviewing experts in the field provides valuable insights and helps expand one's professional network and knowledge base. Time Stamps:  00:00:05 - Podcast Introduction Introducing the Healthy, Wealthy, and Smart podcast with host Dr. Karen Litzy, including a disclaimer about the content. 00:00:27 - Guest Introduction Jenna Cantor introduces Dr. Alyssa Arms, discussing her impressive background and contributions to the physical therapy profession. 00:00:48 - Alyssa's Multifaceted Career Alyssa briefly describes her diverse roles within the theater and physical therapy sectors, including her private practice and work as a professor. 00:01:21 - Podcast Focus and Value of Time The conversation shifts to the importance of the listener's time and Alyssa's understanding of running a niche podcast. 00:02:08 - Dance Med Spotlight Podcast Alyssa shares the title and theme of her own podcast, which focuses on dance medicine and dance science. 00:02:20 - Decision to Start a Podcast Jenna asks Alyssa about her motivations for starting her podcast and the thought process behind it. 00:02:40 - Alyssa's Podcasting Journey Alyssa recounts her initial hesitations and the support she received from Jimmy McKay of P.T. Pintcast, which helped her start her podcast. 00:04:26 - Support Among Podcasters Jenna and Alyssa discuss the supportive nature of the podcasting community and the importance of not worrying about overlapping content. 00:05:08 - Individuality in Podcasting The hosts talk about the uniqueness of each podcast and how different styles and approaches can attract various audiences. 00:06:33 - Interviewing and Learning from Guests Alyssa explains how interviewing guests on her podcast has been a learning experience and has helped her build a professional network. 00:07:04 - Consistency and Time Management The challenges of maintaining a consistent podcast release schedule and managing time effectively are discussed. 00:08:27 - Marketing and Promotion Alyssa touches on the difficulties of marketing a podcast and ensuring it reaches the intended audience. 00:09:00 - Balancing Podcasting with Other Responsibilities Alyssa talks about the struggle of juggling podcasting with her private practice and teaching responsibilities. 00:10:05 - Financial Aspects of Podcasting Jenna inquires about the costs associated with starting and running a podcast, and Alyssa provides a rough estimate. 00:11:05 - The Challenge of Finding Podcast Guests Alyssa discusses the ongoing effort required to find and secure guests for her podcast episodes. 00:12:21 - Return on Investment (ROI) for Niche Podcasts The hosts consider the ROI of running a niche podcast, including the intangible benefits and challenges of not always knowing the impact on listeners. 00:13:30 - Motivations for Running a Niche Podcast Alyssa shares her personal motivations for running her podcast, emphasizing the dissemination of information over financial gain. 00:14:58 - Building Trust and Networking through Podcasting Jenna shares her own reasons for podcasting, focusing on building trust within the dance physical therapy community. 00:16:54 - The Pros of Interviewing Guests Alyssa highlights the benefits of learning from guests and expanding her professional network through her podcast. 00:17:46 - Content Creation and Social Media Presence The conversation shifts to how podcasting can enhance social media content and increase visibility. 00:19:05 - Flexibility and Adaptability in Podcasting Alyssa advises on being adaptable with podcasting goals and being open to shifts in audience and content focus. 00:20:38 - Advice for Aspiring Podcasters Alyssa offers advice to those considering starting a niche podcast, emphasizing organization, persistence, and self-kindness. 00:22:31 - Ultimate Goals for a Niche Podcast Jenna asks about Alyssa's long-term vision for her podcast, and Alyssa expresses her desire for the podcast to at least be self-sustaining financially. 00:24:45 - Final Thoughts and Contact Information Alyssa provides her contact information and final thoughts on the value of podcasting within the dance medicine community.   More About Dr. Alyssa Arms: Dr. Alyssa Arms is the owner of Back in Step Physical Therapy, located in Centennial, Colorado. She attended the University of Denver for her Bachelor of Science in Biology. She then went to the University of Colorado Anschutz Medical Campus for her Doctorate in Physical Therapy. She later obtained a board certification as an Orthopedic Clinical Specialist. Besides her training and experience as a physical therapist, Dr. Alyssa has over 30 years of experience as a dancer, having received training in ballet and pointe, jazz, tap, hip hop, and salsa. She has also been a national circuit competitor in West Coast Swing since 2010. Dr. Alyssa also loves to teach others. She is a Clinical Senior Instructor at her alma mater, CU Anschutz, in the physical therapy program. She has also been a guest instructor in other programs, including the University of Northern Colorado Dance Education Master of Arts program and the Colorado School of Chinese Medicine. In addition, she provide seminars and workshops for a variety of dance organizations and conferences. She is passionate about keeping dancers happy and healthy, whether that's through rehabilitation and recovery, prevention and wellness services, or teaching opportunities for dancers and dance instructors alike!   Resources from this Episode: Dr. Alyssa's website Dance Med Spotlight Podcast Dr. Alyssa's Instagram Dr. Alyssa on Facebook Dr. Alyssa on YouTube   Jane Sponsorship Information: Book a one-on-one demo here Mention the code LITZY1MO for a free month     Follow Dr. Karen Litzy on Social Media: Karen's Twitter Karen's Instagram Karen's LinkedIn   Subscribe to Healthy, Wealthy & Smart: YouTube Website Apple Podcast Spotify SoundCloud Stitcher iHeart Radio

Guest: R. Paul Wadwa, M.D. Since young kids have a different activity level and diet than older kids or adult patients, controlling type 1 diabetes in younger patients can be more challenging, and there tends to be more variability in their blood sugars. However, a recent study identified that hybrid closed-loop technology could help give children with type 1 diabetes the best outcomes and quality of life. To learn more, tune in with Dr. Paul Wadwa, Professor of Pediatrics and the Medical Director of the Pediatric Clinic at the Barbara Davis Center for Diabetes at University of Colorado Anschutz Medical Campus.

Episode Three of "Voices in Genomics," Season Three of Genetically Speaking.  In this episode, host Eli Roberson, PhD interviews Katrina Claw, PhD, an assistant professor at the University of Colorado Anschutz Medical Campus. Dr. Claw shares her career, focused on research in genomics and pharmacogenomics, with an emphasis on underrepresented populations. She also delves into her community-based research approach and addresses the cultural, ethical, legal, and social aspects of genomic research. The episode explores Dr. Claw's involvement in initiatives like the Summer Internship for Indigenous Peoples in Genomics Consortium and the PRIME program, which aims to mentor early-career indigenous faculty.

On this episode of Water Buffs, we examine how drought can harm human health, specifically how dramatic flucutations in water availability can lead to increasingly toxic water supplies. Dr. James is an award-winning epidemiologist and engineer specializing in environmental and climate risk factors and their connection to health in vulnerable populations. She is an associate professor at the University of Colorado Anschutz Medical Campus, one of three institutions that make up the Colorado School of Public Health. Dr. James recently spoke to journalist Melissa Bailey for a Water Desk-supported article, “Once 'paradise,' parched Colorado valley grapples with arsenic in water.” The article, originally published by KFF Health News, centered around Dr. James' community-based research projects that investigate exposure to heavy metals, in particular a rise in carcinogenic arsenic in drinking water in Colorado's drought-stricken San Luis Valley.

Do you like the way you look when you're on Zoom calls? Emily Hemendinger, assistant professor with the department of psychiatry at the University of Colorado Anschutz Medical Campus, says if not, you're not alone. Emily Hemendinger is a Licensed Clinical Social Worker, Assistant Professor with the Department of Psychiatry, and Clinical Director and Deep […]

Samuel David Burciaga, a first-generation Mexican American, earned his Biology degree from the University of Minnesota and is currently in the first year of his Immunology PhD at the University of Colorado Anschutz Medical Campus. Motivated by the challenges of the COVID-19 pandemic, he sees scientific research as a practical tool to unravel complex problems. His academic journey is fueled by a passion for groundbreaking research and a commitment to Diversity, Equity, and Inclusion (DEI). Samuel values collaboration and mentorship, understanding the importance of representation in the scientific community. Beyond academia, Samuel appreciates the collaborative culture at CU Anschutz, which has become home over the past year as his partner completes her medical residency. His aspiration to impact first-generation college students and the Latino community reflects a commitment to leaving a meaningful mark in the Immunology Program. Credits: Our thanks to Sam for coming on the show! Executive Producers: -       Bejan Saeedi -       Joe Behnke -       Michael Sayegh -       Carey Jansen -       Nielsen Weng Faculty Advisors  -       Brian Robinson -       Mary Horton -       Talia Swartz -       Chris Williams -       David Schwartz Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com

Mike Pascoe joins host Kevin Patton in Episode 144 to chat about Mike's experience in editing the new Kenhub Atlas of Human Anatomy. We go behind the scenes to see how this new kind of anatomy atlas was developed. Let's see how those decisions get made and how the learning perspective gets incorporated into anatomy manuals. And we explore diverse representation in anatomy images and why we won't find any eponyms in this atlas. We also have a brief remembrance of our friend David Allard. 00:00 | Introduction 00:45 | Remembering David Allard 04:25 | Introducing Mike Pascoe 06:12 | A New Take on the Human Atlas 19:00 | Debriefing and Predictions Ahead 19:55 | Creating Books 34:25 | Your New Thing 35:44 | More Features of the New Atlas 47:27 | Staying Connected   ★ If you cannot see or activate the audio player, go to: theAPprofessor.org/podcast-episode-144.html

Christopher A. Lowry, Ph.D. is Professor in the Department of Integrative Physiology, Department of Psychology and Neuroscience, Center for Neuroscience, and Center for Microbial Exploration at the University of Colorado Boulder (CU Boulder), with a secondary appointment in the Department of Physical Medicine and Rehabilitation (PM&R) and Center for Neuroscience, University of Colorado Anschutz Medical Campus, a Principal Investigator in the Department of Veterans Affairs Eastern Colorado Health Care System, VA Rocky Mountain Mental Illness Research, Education, & Clinical Center (MIRECC), director of the Behavioral Neuroendocrinology Laboratory at CU Boulder, and Co-Founder and Co-Director of the Military and Veteran Microbiome Consortium for Research and Education (MVM-CoRE). He is a Phi Beta Kappa graduate from the University of Wyoming where he received training in comparative endocrinology. Dr. Lowry was a Wellcome Trust Research Fellow at the University of Bristol, United Kingdom. Dr. Lowry's research program at CU Boulder focuses on understanding stress-related physiology and behavior with an emphasis on the microbiome-gut-brain axis, designed to lead to novel, microbiome-based interventions for the prevention of anxiety disorders, mood disorders, and trauma- and stressor-related disorders, such as posttraumatic stress disorder (PTSD). Dr. Lowry has been a principal investigator on 6 NIH grants, and numerous foundation and industry-sponsored projects. His research accomplishments have been recognized through many awards, including recognition by the Brain & Behavior Research Foundation for Top 10 Advancements & Breakthroughs by Foundation Grantees in 2016. He is a Co-founder of one CU Boulder startup biotech company. Importantly, Dr. Lowry has mentored numerous undergraduate students, graduate students, and postdoctoral fellows who have gone on to successful independent careers in academia, industry, and medicine. Christopher Lowry Lab

Idiopathic Pulmonary Fibrosis, or IPF, is a progressive lung disease with genetic and environmental causes, affecting 5 million people globally. Although pollutants have long been linked to a range of lung diseases,  no conclusive evidence regarding their link to IPF has been sought thus far. The research of Dr. Eun Joo Kim, a post-doctorate researcher at The University of Colorado Anschutz Medical Campus, defines the role of cilia in lung repair following injury, and details how cilia related genes may be responsible for the severity of symptoms.Read the original article: https://doi.org/10.1165/rcmb.2021-0554OC

Dr. Yoni Ashar, Assistant Professor of Internal Medicine at the University of Colorado Anschutz Medical Campus, joined Newsline with Brigitte Quinn to speak about new evidence supporting the effectiveness of brain-based treatments for chronic back pain.

Christopher A. Lowry, Ph.D., is an Associate Professor at the University of Colorado Boulder in the Departments of Integrative Physiology, Psychology, and Neuroscience, the Center for Neuroscience, and the Center for Microbial Exploration. He has additional appointments in the Department of Physical Medicine and Rehabilitation and the Center for Neuroscience at the University of Colorado Anschutz Medical Campus, as a Principal Investigator in the Department of Veterans Affairs Eastern Colorado Health Care System, VA Rocky Mountain Mental Illness Research, Education, & Clinical Center, and as the director of the Behavioral Neuroendocrinology Laboratory at CU Boulder. He is also the Co-Founder and Co-Director of the Military and Veteran Microbiome Consortium for Research and Education.Dr. Lowry's research program at CU Boulder focuses on understanding stress-related physiology and behavior, emphasizing the microbiome-gut-brain axis. His research is designed to lead to novel, microbiome-based interventions for preventing anxiety, mood, and trauma- and stressor-related disorders, such as posttraumatic stress disorder (PTSD).In this episode, we talk with Dr. Lowry about his work involving the microbiome-gut-brain axis, a research term for how our digestive systems' health is intertwined with our brains' health. We'll cover broad theoretical topics like what the gut microbiome is and how it works, to the practical side of things like what you can eat to make it healthier.We'll also discuss some of Chris' work on how the gut biome can affect our resilience and susceptibility to traumatic brain injury and post-traumatic stress, as well as his research in these areas, specifically involving the veteran and first responder communities. Timestamps:00:00:22 Who is Dr. Chris Lowry00:03:08 Background, Education and the Microbiome00:10:28 Where is the Biome00:13:02 What Benefits Our Microbiome00:16:46 How Does Food Diversity Affect the Microbiome 00:20:15 Blood/Gut Barrier00:22:28 Fiber: Diversity is Best00:27:05 How do Antibiotics Affect the Microbiome00:29:13 Recovery From Antibiotics00:30:31 Guidelines in Probiotic Diversity00:35:00 Outro

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Abbott acquires Bigfoot, a new study looks at low-dose aspirin to prevent type 2, researchers look into whether the AI ChatGPT can answer FAQs about diabetes, Beyond Type Run is back for the NYC Marathon, and more! Our previous episode with Bigfoot Biomedical: https://diabetes-connections.com/?s=bigfoot Join us for Moms' Night Out! (use promo code School30 to save) Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Learn about Edgepark Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines happening now XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX Our top story this week – Abbott scoops up Bigfoot Biomedical. The deal is expected to close later this year – no financial terms yet disclosed. Abbott and Bigfoot have worked together since 2017 on a connected insulin pen system. Bigfoot Unity exclusively works with Abbott's FreeStyle Libre® Long time listeners will recall that Bigfoot was founded in 2015 around serving people with type 1 diabetes with a closed loop pump system that Byran Mazlish had developed for his wife and son. Mazlish was very secretive at first about the algorithm – this was before people were sure the FDA wouldn't crack down on them – so a journalist nicknamed him Bigfoot. Along the way, the company pivoted to CGM connected SmartPens. I believe Bigfoot was my third interview, back in 2015 – I'll ink up all of the interviews I've done with them in the show notes. https://diabetes-connections.com/?s=bigfoot https://www.prnewswire.com/news-releases/abbott-to-acquire-bigfoot-biomedical-furthering-efforts-to-develop-personalized-connected-solutions-for-people-with-diabetes-301918254.html XX Low-dose aspirin reduces the risk for type 2 diabetes among older adults and slows the increase in fasting glucose levels over time, new research finds. The data come from a secondary analysis of ASPREE, a double-blind, placebo-controlled trial of healthy adults aged 65 years or older, showing that 100 mg of aspirin taken daily for about 5 years did not provide a cardiovascular benefit but did significantly raise the risk for bleeding. It's a big study, more than 16-thousand people. This new analysis shows that individuals taking aspirin had a 15% lower risk for developing type 2 diabetes and that the medication slowed the rate of increase in fasting plasma glucose, compared with placebo, during follow-up. However, lead author Sophia Zoungas, MBBS, PhD, head of the School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, says, "Major prescribing guidelines now recommend older adults take daily aspirin only when there is a medical reason to do so, such as after a heart attack… Although these new findings are of interest, they do not change the clinical advice about aspirin use in older people at this time." https://www.medscape.com/viewarticle/996058 XX A class-action lawsuit filed against Medtronic (NYSE: MDT)+ alleges that the company's insulin delivery devices shared patient data with third parties. The lawsuit — filed by the plaintiff “A.H.” in U.S. District Court in Central California — levels allegations against Medtronic and its MiniMed and InPen devices. It addresses MiniMed's transmission and disclosure of personally identifiable information and protected health information to Google and other third parties. Per the lawsuit, the data was transmitted via tracking and authentication technology, including Google Analytics, Crashlytics, Firebase Authentication and related tools. A.H. says these technologies, installed on the website and/or mobile applications, include the InPen iOS and Android applications. “Information about a person's health is among the most confidential and sensitive information in society, and its mishandling can have serious consequences, including embarrassment, discrimination, and denial of insurance coverage,” the lawsuit reads. A Medtronic spokesperson issued the following statement via email: We have strong processes, technologies, and people in place to safeguard and protect our information and systems, the information of our business partners, and most importantly, the privacy and safety of the patients and healthcare providers that use our products.” https://www.massdevice.com/lawsuit-patient-data-sharing-medtronic-diabetes/ XX Interesting new way to look at type 2 – not weight loss or medication, but about reducing how much blood glucose goes up and stays up after eating and drinking. University of Virginia Daniel Cox says this is called Glucose Everyday Matters, or GEM – aims to prevent blood sugar spikes via educated food and drink selection. This is coupled with physical activity to hasten recovery when blood-sugar spikes do occur. So someone might indulge in a piece of fruit or a small, sweet treat, knowing how it will affect them, and then go for an evening stroll to help even out their blood sugar. Sounds really simple, but in its first study, it helps almost 70-percent of people put their type 2 into remission without weight loss or medication. The National Institutes of Health has provided $3.5 million for a large-scale clinical trial Cox himself went from an A1C of 10.3 at the time of diagnoses to reading consistently under 6.0 for the past 13 years on no medication using his approach. https://newsroom.uvahealth.com/2023/08/31/radical-new-approach-to-managing-type-2-diabetes-receives-3-5-million/ XX Final preparations are in place to initiate the first clinical site for DIAGNODE-3 in the United States, and additional sites are expected to be initiated over the coming months. Approximately 10-12 clinical sites across the US are planned to be initiated, expanding the DIAGNODE-3 trial in the US and eight European countries to approximately 60 clincal sites in total. DIAGNODE-3 is designed to confirm the efficacy and safety of the antigen-specific immunotherapy Diamyd® in patients aged 12 to 29 years recently diagnosed with type 1 diabetes and carrying the genetic HLA DR3-DQ2 marker. Approximately 40% of all screened patients carry the genetic HLA DR3-DQ2 haplotype. This proportion aligns well with expectations based on previous Diamyd® clinical trials and published epidemiological research. Supported by published retrospective analyses and prospective clinical trials, the presence of the genetic HLA DR3-DQ2 haplotype determines the likelihood of responding to Diamyd® therapy, and serves as one of the main inclusion criteria in the DIAGNODE-3 trial. "Patient recruitment is a complex and central element in any trial and it is encouraging to see a significant and continuous uptick in the screening rate and that the observed frequency of the genetically defined responder group enrolled into DIAGNODE-3 confirms our previous observations", says Ulf Hannelius, President & CEO of Diamyd Medical. "This shows the operational and clinical feasibility of our precision medicine approach to Type 1 Diabetes and we look forward to expanding the trial to the United States". https://finance.yahoo.com/news/registrational-phase-iii-trial-type-142600082.html XX A low-carbohydrate diet during pregnancy may have some benefits in gestational diabetes, but overall, low-carbohydrate diets are not associated with any significant differences in outcomes. That was the conclusion of a presentation at the ADA Scientific Sessions. That was back in June but I just learned about it, so I'm passing along to you in case you missed it as well. During a debate at the American Diabetes Association Scientific Sessions, Amy M. Valent, DO, MCR, associate professor in the division of maternal-fetal medicine in the department of obstetrics and gynecology at Oregon Health & Science University, said identifying Teri L. Hernandez, PhD, RN, associate dean of research and scholarship in the College of Nursing and professor in the department of medicine and the division of endocrinology, metabolism and diabetes at the University of Colorado Anschutz Medical Campus, agreed that the first line of therapy with gestational diabetes is nutrition. However, Hernandez said, low-carbohydrate diets are not the only approach in gestational diabetes treatment with nutrition. Currently, dietary advice for treating gestational diabetes is inconsistent, and current professional guidelines have limitations and biases, according to Valent. Different diet strategies include low-carbohydrate, low glycemic index and total energy restriction eating plans, according to Valent. Valent said ACOG guidelines recommended a low-carbohydrate diet for gestational diabetes until the most recently revised edition in January. Valent reviewed several major landmark studies demonstrating that gestational diabetes treatment can decrease pregnancy complications such as preeclampsia and large for gestational age infants. “These studies were in the era where treatment of diabetes in pregnancy involved recommending a low-carbohydrate diet,” Valent said. “The concern with lowering carbohydrates is the risk of consuming lower nutrient-dense foods and resulting in the body to produce ketones, which may be associated with negative effects on the developing baby.” “Pregnancy is dynamic. Nobody's the same today as they were yesterday. They're going to be different 1, 2 or 3 weeks from now, and the nutritional demands and the fetal growth and development stage are going to be different,” Valent said. “So, nutritional demands are going to vary.” Hernandez also added that women and girls tend to be priced out of good nutritional patterns, which is an issue not only in the pregnancy field, but also in the global community. According to Hernandez, it is important to create ways moving forward to identify what nutritional patterns are best that are also affordable for families, especially in lower-income settings. https://www.healio.com/news/womens-health-ob-gyn/20230905/experts-debate-benefits-of-lowcarb-diets-for-gestational-diabetes XX XX Commercial – Edgepark XX Can ChatGPT help answer questions about diabetes? In a recent study published in the journal PLoS ONE, researchers tested chatGPT, a language model geared for discussion, to investigate whether it could answer frequently asked diabetes questions. In the present study, researchers evaluated ChatGPT's expertise in diabetes, especially the capacity to answer commonly requested questions related to diabetes in a similar manner as humans. The 'Frequently Asked Questions' section of the Diabetes Association of Denmark's website, viewed on 10 January 2023, included eight questions. The researchers designed the remaining questions to correlate to particular lines on the 'Knowledge Center for Diabetes website and a report on physical activity and diabetes mellitus type 1. Across the 10 questions, the proportion of correct responses ranged from 38% to 74%. Participants correctly identified ChatGPT-generated replies 60% of the time, which was over the non-inferiority threshold. Males and females had 64% and 58% chances of accurately recognizing the artificial intelligence-generated response, respectively. Individuals who had past contact with diabetes patients had a 61% chance of precisely answering the questions, compared to 57% for those who had no prior contact with diabetes patients. In contrast to the initial premise, participants could discern between ChatGPT-generated and human-written replies better than tossing a fair coin. While ChatGPT demonstrated some potential for accurately answering frequently asked questions, issues around misinformation and the lack of nuanced, personalized advice were evident. As large language models increasingly intersect with healthcare, rigorous studies are essential to evaluate their safety, efficacy, and ethical considerations in patient care, emphasizing the need for robust regulatory frameworks and continuous oversight. https://www.news-medical.net/news/20230905/Can-ChatGPT-be-a-diabetes-consultant-Study-probes-the-potential-and-pitfalls.aspx XX SAN MATEO, Calif., Aug. 24, 2023 /PRNewswire/ -- On November 5, diabetes nonprofit Beyond Type 1 will join more than 550 official charity partners and philanthropists raising awareness and funds while participating in the world's largest marathon, the TCS New York City Marathon. This year, the organization is expanding its 50-person team, Beyond Type Run, to include people living with type 1 or type 2 diabetes, as well as caregivers to those living with diabetes. "Since 2017, we've featured more than 200 runners on our teams who've exemplified what it means to survive and thrive with diabetes," said Beyond Type 1 CEO Deborah Dugan. Beyond Type 1 announces the 2023 NYC Marathon team to raise awareness and funds for people living with diabetes As a part of the Beyond Type Run team, runners will be advocating to raise awareness and funds for Beyond Type 1's portfolio of educational resources, awareness campaigns and peer-to-peer support programs for people impacted by diabetes. This advocacy is elevated through the NYRR Official Charity Partner Program, which offers opportunities for nonprofit organizations to raise funds to support their missions and services. Dexcom and Tandem Diabetes Care are presenting sponsors of Beyond Type Run for a fourth consecutive year. The TCS New York City Marathon Official Charity Partner Program has raised more than $440 million for more than 1,000 nonprofit organizations since its establishment in 2006. https://www.prnewswire.com/news-releases/team-of-50-individuals-impacted-by-diabetes-prepare-for-the-2023-tcs-new-york-city-marathon-301909163.html XX MNO update On the podcast next week.. tandem diabetes celebrity panel from friends for life – Hollywood, the NFL and NASCAR. Last week's episode was Benny off to college That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon. ----  

Why does having a deeper connection to your pelvic floor lead to better orgasms? Does the same apply to penises and asses? How is squatting and peeing related? What are some of the best positions and tools (sex toys!) for a healthy pelvic floor (aka better orgasms)? Oh, and can a penis really break? About our guest: Dr. Meredith Brezinski is a pelvic health and orthopedic physical therapist located in Portland, Oregon. Meredith provides one-on-one, in home, concierge physical therapy services which eliminates the stress of commuting to an appointment, hiring childcare, and worrying about sharing the intimate details of your story with an entire clinic. Dr. Meredith knows that every person has a story to share and having time with your provider is often the piece that is lacking in our traditional healthcare system. Meredith will help you determine the root cause of your symptoms, develop a plan for relief, and help you get back to what is most important - living your best life! Meredith also serves as the Director of Pelvic Health for Concierge Physical Therapists, a nationwide company, that offers all in home services to their clients. We have therapists in 14 different states in the US and continue to grow to more locations. If you are interested in finding a therapist near you, you can find out more info at www.conciergephysicaltherapists.com. Meredith received her Doctorate of Physical Therapy at University of Colorado Anschutz Medical Campus in 2016 following her Bachelor of Science in Exercises Physiology at West Virginia University in 2013. She has completed numerous courses specific to pelvic health through Herman and Wallace Pelvic Rehabilitation Institute.  Meredith loves everything outdoors and can be found hiking, backpacking, on the water, or hanging out with her dogs Luke and Leia. She lives with her husband Will in Portland Oregon. To learn more visit www.drmeredithbrezinskipt.com Join us November 1st-6th, 2023 for The Shameless Sex Retreat: Unleash Your Shameless Self - in Costa Rica! Spaces are limited to reserve your spot ASAP here Other links: Get turned on with 30 days free of super hot audio erotica at dipseastories.com/shameless Get silky skin with 25% off our favorite adorable razors with code SHAMELESS at athenaclub.com Get 10% off + free shipping with code SHAMELESS10 on Uberlube AKA our favorite lubricant at uberlube.com Get 10% off while mastering the art of pleasure at  OMGyes.com/shameless Get 15% off all of your sex toys with code SHAMELESSSEX at purepleasureshop.com